DK0442372T3 - Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays - Google Patents

Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays

Info

Publication number: DK0442372T3
Authority: DK; Denmark
Prior art keywords: haptenes; labeled; preparation; immunoassays; methods
Prior art date: 1990-02-13

Application number

DK91101656.6T

Other languages

English (en)

Inventor

Tonio Dr Kinkel

Andreas Dr Mayer

Stephan Dr Neuenhofer

Raymond Dr Oekonomopulos

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-13

Filing date

1991-02-07

Publication date

1995-09-25

1991-02-07 Application filed by Hoechst Ag filed Critical Hoechst Ag

1995-09-25 Application granted granted Critical

1995-09-25 Publication of DK0442372T3 publication Critical patent/DK0442372T3/da

Links

238000000034 method Methods 0.000 title abstract 2
238000003018 immunoassay Methods 0.000 title 1
229920001223 polyethylene glycol Polymers 0.000 abstract 2
102000015636 Oligopeptides Human genes 0.000 abstract 1
108010038807 Oligopeptides Proteins 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
229940088623 biologically active substance Drugs 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
125000006850 spacer group Chemical group 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK91101656.6T 1990-02-13 1991-02-07 Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays DK0442372T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4004296A DE4004296A1 (de)	1990-02-13	1990-02-13	Verbesserte markierte haptene, verfahren zu deren herstellung sowie verwendung dieser markierten haptene in immunoassays

Publications (1)

Publication Number	Publication Date
DK0442372T3 true DK0442372T3 (da)	1995-09-25

Family

ID=6399985

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91101656.6T DK0442372T3 (da)	1990-02-13	1991-02-07	Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays

Country Status (5)

Country	Link
EP (1)	EP0442372B1 (da)
AT (1)	ATE122149T1 (da)
DE (2)	DE4004296A1 (da)
DK (1)	DK0442372T3 (da)
ES (1)	ES2074179T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU689920B2 (en) *	1994-06-24	1998-04-09	Dade Behring Marburg Gmbh	Method of stabilizing molecules, or parts of molecules, which are sensitive to hydrolysis
DE4444002A1 (de) *	1994-12-10	1996-06-13	Behringwerke Ag	Immunoassays für Haptene und hierfür verwendbare Haptentracer-Antikörper-Komplexe sowie Verfahren zur Herstellung derselben
US6544797B1 (en) *	1997-04-09	2003-04-08	Biosite Diagnostics, Inc.	Compositions and methods for inhibiting light-induced inactivation of biological reagents
DE19748489A1 (de)	1997-11-03	1999-05-06	Roche Diagnostics Gmbh	Polyethylenglykol-derivatisierte Biomoleküle und deren Verwendung in heterogenen Nachweisverfahren
AU751434B2 (en) *	1997-12-23	2002-08-15	Inex Pharmaceuticals Corporation	Polyamide oligomers
US6320017B1 (en)	1997-12-23	2001-11-20	Inex Pharmaceuticals Corp.	Polyamide oligomers
US7163918B2 (en)	2000-08-22	2007-01-16	New River Pharmaceuticals Inc.	Iodothyronine compositions
US6664043B2 (en) *	2001-07-03	2003-12-16	Bayer Corporation	Acridinium ester labels having hydrophilic modifiers
ATE553089T1 (de) *	2002-08-20	2012-04-15	Quest Diagnostics Invest Inc	Hydrophile, chemilumineszente acridiniummarkierungsreagenzien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3379659D1 (en) *	1983-07-29	1989-05-24	Henning Berlin Gmbh	Preactivated surfaces of synthetic materials for immobilizing organochemical and biological substances, process for preparing them and their use
US4732863A (en) *	1984-12-31	1988-03-22	University Of New Mexico	PEG-modified antibody with reduced affinity for cell surface Fc receptors
US4810638A (en) *	1986-07-24	1989-03-07	Miles Inc.	Enzyme-labeled antibody reagent with polyalkyleneglycol linking group
DE3628795A1 (de) *	1986-08-25	1988-03-03	Hoechst Ag	Neue thyroninderivate

1990
- 1990-02-13 DE DE4004296A patent/DE4004296A1/de not_active Withdrawn
1991
- 1991-02-07 EP EP91101656A patent/EP0442372B1/de not_active Expired - Lifetime
- 1991-02-07 ES ES91101656T patent/ES2074179T3/es not_active Expired - Lifetime
- 1991-02-07 AT AT91101656T patent/ATE122149T1/de not_active IP Right Cessation
- 1991-02-07 DK DK91101656.6T patent/DK0442372T3/da active
- 1991-02-07 DE DE59105344T patent/DE59105344D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2074179T3 (es)	1995-09-01
DE4004296A1 (de)	1991-08-14
EP0442372B1 (de)	1995-05-03
EP0442372A1 (de)	1991-08-21
DE59105344D1 (de)	1995-06-08
ATE122149T1 (de)	1995-05-15

Similar Documents

Publication	Publication Date	Title
DK338587A (da)	1987-07-01	Modulsamling af antistofgener, antistoffer fremstillet derved samt anvendelse deraf
ES2188583T3 (es)	2003-07-01	Polipeptidos para el virus de la hepatitis c (hcv).
DE69133095D1 (de)	2002-10-02	Cyclosporin-Immunoassay
DE3750339D1 (de)	1994-09-15	HTLV-III umhüllende Peptiden.
EP0029063A4 (en)	1982-01-11	DETERMINATION OF THE NON-A, NON-B HEPATITIS ANTIGENS.
ES2123677T3 (es)	1999-01-16	Ligadores de maleinimida trifuncionales homobidentados y su uso en conjugados inmunologicamente activos.
FR2522967B1 (fr)	1986-03-07	Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
DK0442372T3 (da)	1995-09-25	Forbedrede mærkede haptener, fremgangsmåde til deres fremstilling samt anvendelse af disse mærkede haptener ved immunoassays
DE68912462D1 (de)	1994-03-03	Xanthenfarbstoffe.
DE69033080D1 (de)	1999-06-02	Zuwachsfaktorrezeptorgen deriviert von platten des typs oc
SE8902148D0 (sv)	1989-06-13	Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE196767T1 (de)	2000-10-15	Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
DE58904672D1 (de)	1993-07-22	Verfahren zur herstellung einer festphasenmatrix.
FI924368A0 (fi)	1992-09-29	Expression av heterologiskt protein i jaest.
ATE52251T1 (de)	1990-05-15	Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
FR2397449A1 (fr)	1979-02-09	Produits conjugues chimioluminescents biologiquement actifs et leur utilisation
DE69434087D1 (de)	2004-11-25	ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
DE69026812D1 (de)	1996-06-05	Konjugate von "pokeweed" antiviralem protein und monoklonalen antikörpern
DK116487D0 (da)	1987-03-06	Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
DE69104012D1 (de)	1994-10-20	Rekombiniebares Hepatitis-Delta-Antigen, Verfahren zu seiner Reinigung und Verwendung.
NO910479L (no)	1991-04-05	Syntetiske polypeptider og antistoffer relatert til epstein-barr-virus-kjerneantigen.
SE8705137D0 (sv)	1987-12-22	Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
DE59209899D1 (de)	2001-05-10	Rekombinante Proteine mit der Immunreaktivität des Hepatitis B Virus e Antigens (HBeAg), Verfahren zu ihrer Herstellung und ihre Verwendung in Immunoassays und Impfstoffen
NO904742D0 (no)	1990-11-01	Rekobinant immunogen (antistoff mot membranmolekyler paa antigenpresenterende celler koplet med immunogene peptider).